Pharming Group N.V. (PHAR) Net margin 2019–2025
Pharming Group N.V. (PHAR) net profit margin by fiscal year — reported net income divided by reported revenue.
0.8%FY2025 · since FY2019: 21.4% → 0.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 0.8% | +4.7 pp |
| FY2024 | -4.0% | +0.3 pp |
| FY2023 | -4.3% | -10.9 pp |
| FY2022 | 6.7% | -1.4 pp |
| FY2021 | 8.0% | -9.7 pp |
| FY2020 | 17.8% | -3.6 pp |
| FY2019 | 21.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice